In the opinion of Stolzenberg-Solomon et al. (systematic reviews and meta- and pooled analyses), there is an association between higher prediagnostic circulating leptin concentrations and increased pancreatic cancer risk observed in patients with longer follow-ups. This evidence concerns the gene LEP and familial pancreatic carcinoma.